Replies to post #169740 on Biotech Values

[oc631]

This is a phase 2/3 study so has been enrolling in the phase 2 safety cohort for awhile. Data from this portion should be available shortly. There has not yet been anything to indicate they have formally advanced into phase 3

What you are saying makes sense. I checked this study a couple of weeks ago and I don't recall seeing the "currently recruiting participants" status. There was a study recruitment date change done last Tuesday which I thought may indicate enrollment into the Phase-3 portion of the study. So this was a print from Phase-2 enrollment? Wishful thinking on my part.

[oc631]

MK-8931 (MRK, LGND)

There has not yet been anything to indicate they have formally advanced into phase 3.

Update: MRK started enrolling in the Phase-3 Prodromal study.




http://clinicaltrials.gov/ct2/show/NCT01953601?term=MK-8931&rank=3